论文部分内容阅读
肝门部胆管癌(hilar cholangiocarcinoma,HCCA)是来源于胆管上皮细胞,发生在左、右肝管及其汇合部和肝总管上段的恶性肿瘤。由于最先由Klatskin[1]在1965年报道,故又称为Klatskin瘤。最初的治疗仅停留在通过引流梗阻性胆管来缓解症状、延长生命上,如今由于多学科治疗技术的进步,治疗方式已从非手术治疗转变为手术治疗,最有效地治
Hilar cholangiocarcinoma (HCC) is a malignant tumor that originates from biliary epithelial cells and occurs in the left and right hepatic ducts and their confluence and the upper hepatic duct. As first reported by Klatskin [1] in 1965, it is also known as Klatskin’s tumor. The initial treatment only remained to relieve symptoms and prolong life by draining obstructive bile duct. Nowadays, due to the progress of multi-disciplinary treatment, the treatment has been transformed from non-surgical treatment to surgical treatment, and the most effective treatment